Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528K Buy
5,697
+250
+5% +$23.3K 0.01% 362
2026
Q1
$529K Buy
5,447
+27
+0.5% +$2.47K 0.01% 355
2025
Q4
$479K Sell
5,420
-289
-5% -$26.3K 0.01% 376
2025
Q3
$514K Buy
+5,709
New +$462K 0.01% 375
2023
Q1
Sell
-4,732
Closed -$366K 453
2022
Q4
$366K Buy
+4,732
New +$366K 0.01% 341

Other funds holding SRE

Glenview Trust's SRE Position: Q2 2026 in Review

Glenview Trust increased its Sempra (SRE) stake by 4.6% in Q2 2026, buying an estimated $23.3K and bringing the position to 5,697 shares worth $528K. The position accounts for 0.01% of the portfolio, ranked #362.

Glenview Trust first reported a position in SRE in Q4 2022 and has held it in 5 quarters since. The position peaked at $529K in Q1 2026. 1,283 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Glenview Trust held 5,697 shares of Sempra worth $528K as of Q2 2026.
  • Glenview Trust bought 250 Sempra shares in Q2 2026, an estimated $23.3K.
  • Sempra made up 0.01% of Glenview Trust's portfolio in Q2 2026, its #362 holding.
  • Glenview Trust first reported a position in Sempra in Q4 2022 and has held it in 5 quarters since.
  • Glenview Trust's Sempra position peaked at $529K in Q1 2026.
  • 1,283 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.